Hims & Hers Enters Testosterone Market: Stock Surges
Update: 2025-09-10
Description
Hims & Hers stock jumps as the telehealth giant dives into testosterone replacement therapy, offering personalized treatments and a needle-free oral option. Is this a game-changer for the company's growth in men's health, or just another volatile swing for this unpredictable stock? Plus, a revenue forecast boost adds to the investor buzz.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
